275 related articles for article (PubMed ID: 24036073)
1. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
[TBL] [Abstract][Full Text] [Related]
2. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
3. Humanized-VHH transbodies that inhibit HCV protease and replication.
Jittavisutthikul S; Thanongsaksrikul J; Thueng-In K; Chulanetra M; Srimanote P; Seesuay W; Malik AA; Chaicumpa W
Viruses; 2015 Apr; 7(4):2030-56. PubMed ID: 25903832
[TBL] [Abstract][Full Text] [Related]
4. Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV.
Thueng-in K; Thanongsaksrikul J; Srimanote P; Bangphoomi K; Poungpair O; Maneewatch S; Choowongkomon K; Chaicumpa W
PLoS One; 2012; 7(11):e49254. PubMed ID: 23145135
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HCV replication by humanized-single domain transbodies to NS4B.
Glab-Ampai K; Malik AA; Chulanetra M; Thanongsaksrikul J; Thueng-In K; Srimanote P; Tongtawe P; Chaicumpa W
Biochem Biophys Res Commun; 2016 Aug; 476(4):654-664. PubMed ID: 27240954
[TBL] [Abstract][Full Text] [Related]
6. Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus.
Glab-Ampai K; Chulanetra M; Malik AA; Juntadech T; Thanongsaksrikul J; Srimanote P; Thueng-In K; Sookrung N; Tongtawe P; Chaicumpa W
Sci Rep; 2017 Nov; 7(1):15042. PubMed ID: 29118372
[TBL] [Abstract][Full Text] [Related]
7. Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate Immunity.
Jittavisutthikul S; Seesuay W; Thanongsaksrikul J; Thueng-In K; Srimanote P; Werner RG; Chaicumpa W
Front Immunol; 2016; 7():318. PubMed ID: 27617013
[TBL] [Abstract][Full Text] [Related]
8. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
[TBL] [Abstract][Full Text] [Related]
9. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
[TBL] [Abstract][Full Text] [Related]
11. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.
Furuta A; Tsubuki M; Endoh M; Miyamoto T; Tanaka J; Salam KA; Akimitsu N; Tani H; Yamashita A; Moriishi K; Nakakoshi M; Sekiguchi Y; Tsuneda S; Noda N
Int J Mol Sci; 2015 Aug; 16(8):18439-53. PubMed ID: 26262613
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient.
Provazzi PJ; Mukherjee S; Hanson AM; Nogueira ML; Carneiro BM; Frick DN; Rahal P
PLoS One; 2015; 10(12):e0144638. PubMed ID: 26658750
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolones inhibit HCV by targeting its helicase.
Khan IA; Siddiqui S; Rehmani S; Kazmi SU; Ali SH
Antivir Ther; 2012; 17(3):467-76. PubMed ID: 22293206
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
17. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
18. Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase.
Tessmann K; Erhardt A; Häussinger D; Heintges T
J Virol Methods; 2002 May; 103(1):75-88. PubMed ID: 11906735
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
[TBL] [Abstract][Full Text] [Related]
20. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
